IV Antibiotics for Severe Cellulitis
For severe cellulitis requiring intravenous therapy, vancomycin (30 mg/kg/day in 2 divided doses IV) is the recommended first-line treatment, particularly when MRSA is suspected. 1
First-Line IV Antibiotic Options
For MRSA Coverage (Purulent Cellulitis)
- Vancomycin: 30 mg/kg/day in 2 divided doses IV (adults); 40 mg/kg/day in 4 divided doses IV (children) 1
- Linezolid: 600 mg every 12 hours IV 1
- Daptomycin: 4 mg/kg every 24 hours IV 1, 2
- Ceftaroline: 600 mg twice daily IV 1
For Non-MRSA Coverage (Non-purulent Cellulitis)
- Nafcillin or Oxacillin: 1-2 g every 4-6 hours IV 1
- Cefazolin: 1 g every 8 hours IV 1
- Clindamycin: 600-900 mg every 6-8 hours IV 1
Decision Algorithm for IV Antibiotic Selection
Assess severity and type of cellulitis:
- Purulent (with drainage/exudate): Consider MRSA coverage
- Non-purulent (no drainage/exudate): Target beta-hemolytic streptococci
For severe non-purulent cellulitis:
For severe purulent cellulitis or MRSA risk factors:
For necrotizing infections or polymicrobial infections:
Special Considerations
Outpatient IV Therapy Options
- Once-daily ceftriaxone (1 g IV) has been shown effective for moderate-to-severe cellulitis in outpatient settings 3
- Once-daily cefazolin (2 g IV) plus oral probenecid (1 g) is an effective alternative to ceftriaxone for outpatient treatment 3
- Note: Patients with chronic venous disease have higher failure rates with this regimen 4
- Twice-daily cefazolin (2 g IV) is another effective outpatient option 5
When to Switch to Oral Therapy
- Consider switching to oral antibiotics after 24-48 hours of IV therapy if:
- Clinical improvement is observed
- Fever has resolved
- Erythema and swelling are improving
- Patient can tolerate oral medications
Duration of Therapy
- Standard duration: 5-10 days total (IV + oral) 6
- 5 days is as effective as 10 days for uncomplicated cases 6
Important Caveats
- Obtain cultures when possible, especially in severe cases, to guide targeted therapy 6
- Consider surgical consultation for aggressive infections with signs of systemic toxicity or suspected necrotizing fasciitis 1
- Monitor closely for treatment failure, especially in patients with comorbidities like chronic venous disease 4
- Daptomycin has been shown effective in clinical trials for complicated skin and skin structure infections, with similar success rates to vancomycin or semi-synthetic penicillins 2
- In areas with high MRSA prevalence, empiric coverage for MRSA is crucial for treatment success 7
By following this evidence-based approach to IV antibiotic selection for severe cellulitis, you can optimize outcomes while minimizing complications and treatment failures.